Search
for
Sort by
Research 271–300 of 1000+
- Topical tofacitinib in treatment of alopecia areata
- Syphilis: today
- Diuretics
- An Open-Label Evaluator Blinded Study of the Efficacy and Safety of a New Nutritional Supplement in Androgenetic Alopecia: A Pilot Study.
- Mister XX
- Hyperandrogenism insulin resistance-acanthosis nigricans syndrome in a female adolescent with migraine: A case report
- Mesenchymal Stem Cells from Mouse Hair Follicles Inhibit the Development of Type 1 Diabetes
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Sesame and Pumpkin Seed Oil are New Effective Topical Therapies for Alopecia Areata
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse
- Update on nail disorders
- Long COVID syndrome: An unfolding enigma
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Hormone therapy in acne
- The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
- Obesity and polycystic ovary syndrome
- Folliculitis decalvans: a multicentre review of 82 patients
- Androgenic alopecia and insulin resistance: are they really related?
- Cure of alopecia areata after eradication of Helicobacter pylori: a new association?
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
- Endocrine evaluation of hirsutism
- Polycystic ovary syndrome: An update on diagnosis and management
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 1 approved]
- ANNOUNCEMENTS
- Psychiatry, Medicine
- The prevalence of metabolic syndrome in male patients of early onset androgenic alopecia compared to age matched controls
- Dermatoses of pregnancy
- How should postmenopausal androgen excess be evaluated?
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being